Study of botulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: A prospective, randomized, controlled trial.

Natthachat JurairattanapornPasita PalakornkittiTanaporn AnuntrangseeVasanop Vachiramon

Published in: Journal of cosmetic dermatology (2022)

Intradermal BTX-A injection had no therapeutic effect on UVB-induced hyperpigmentation. However, the role of BTX-A injections in the treatment of other hyperpigmentary conditions requires further elucidation.

Keyphrases

randomized controlled trial
botulinum toxin
high glucose
diabetic rats
study protocol
clinical trial
drug induced
combination therapy
oxidative stress
endothelial cells
replacement therapy
platelet rich plasma